UNDERSTANDING OF BIOLOGICS ALLOWS FOR GENERIC VERSIONS, GPhA SAYS
Generic firms should be allowed to enter the U.S. biopharmaceutical market as they have overseas, according to a generic industry leader who says there have been great advances in the knowledge of the complex molecules.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.